Tobramycin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 14 USDMF, 7 CEP/COS, 1 JDMF, 12 KDMF, 8 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

167 FDF Dossiers, 36 FDA Orange Book, 65 Europe, 7 Canada, 16 Australia, 13 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 28MG, SOLUTION/DROPS;OPHTHALMIC - 0.3%, OINTMENT;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SOLUTION;INHALATION - 300MG/5ML, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 7 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 6 Actylis, 1 BASF, 1 Curia, 3 Finar, 1 Microlex e.U, 1 Nippon Fine Chemical, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

10 Topical, 9 Thickeners and Stabilizers, 7 Parenteral, 6 Solubilizers, 5 Rheology Modifiers, 2 Emulsifying Agents, 2 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Dry Powder Inhalation, 1 Fillers, Diluents & Binders